Cargando…

Pyrrolidine dithiocarbamate administered during ex-vivo lung perfusion promotes rehabilitation of injured donor rat lungs obtained after prolonged warm ischemia

Damaged lung grafts obtained after circulatory death (DCD lungs) and warm ischemia may be at high risk of reperfusion injury after transplantation. Such lungs could be pharmacologically reconditioned using ex-vivo lung perfusion (EVLP). Since acute inflammation related to the activation of nuclear f...

Descripción completa

Detalles Bibliográficos
Autores principales: Francioli, Cyril, Wang, Xingyu, Parapanov, Roumen, Abdelnour, Etienne, Lugrin, Jérôme, Gronchi, Fabrizio, Perentes, Jean, Eckert, Philippe, Ris, Hans-Beat, Piquilloud, Lise, Krueger, Thorsten, Liaudet, Lucas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360331/
https://www.ncbi.nlm.nih.gov/pubmed/28323904
http://dx.doi.org/10.1371/journal.pone.0173916
_version_ 1782516575518064640
author Francioli, Cyril
Wang, Xingyu
Parapanov, Roumen
Abdelnour, Etienne
Lugrin, Jérôme
Gronchi, Fabrizio
Perentes, Jean
Eckert, Philippe
Ris, Hans-Beat
Piquilloud, Lise
Krueger, Thorsten
Liaudet, Lucas
author_facet Francioli, Cyril
Wang, Xingyu
Parapanov, Roumen
Abdelnour, Etienne
Lugrin, Jérôme
Gronchi, Fabrizio
Perentes, Jean
Eckert, Philippe
Ris, Hans-Beat
Piquilloud, Lise
Krueger, Thorsten
Liaudet, Lucas
author_sort Francioli, Cyril
collection PubMed
description Damaged lung grafts obtained after circulatory death (DCD lungs) and warm ischemia may be at high risk of reperfusion injury after transplantation. Such lungs could be pharmacologically reconditioned using ex-vivo lung perfusion (EVLP). Since acute inflammation related to the activation of nuclear factor kappaB (NF-κB) is instrumental in lung reperfusion injury, we hypothesized that DCD lungs might be treated during EVLP by pyrrolidine dithiocarbamate (PDTC), an inhibitor of NF-κB. Rat lungs exposed to 1h warm ischemia and 2 h cold ischemia were subjected to EVLP during 4h, in absence (CTRL group, N = 6) or in presence of PDTC (2.5g/L, PDTC group, N = 6). Static pulmonary compliance (SPC), peak airway pressure (PAWP), pulmonary vascular resistance (PVR), and oxygenation capacity were determined during EVLP. After EVLP, we measured the weight gain of the heart-lung block (edema), and the concentration of LDH (cell damage), proteins (permeability edema) and of the cytokines IL-6, TNF-α and CINC-1 in bronchoalveolar lavage (BAL), and we evaluated NF-κB activation by the degree of phosphorylation and degradation of its inhibitor IκBα in lung tissue. In CTRL, we found significant NF-κB activation, lung edema, and a massive release of LDH, proteins and cytokines. SPC significantly decreased, PAWP and PVR increased, while oxygenation tended to decrease. Treatment with PDTC during EVLP inhibited NF-κB activation, did not influence LDH release, but markedly reduced lung edema and protein concentration in BAL, suppressed TNFα and IL-6 release, and abrogated the changes in SPC, PAWP and PVR, with unchanged oxygenation. In conclusion, suppression of innate immune activation during EVLP using the NF-κB inhibitor PDTC promotes significant improvement of damaged rat DCD lungs. Future studies will determine if such rehabilitated lungs are suitable for in vivo transplantation.
format Online
Article
Text
id pubmed-5360331
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-53603312017-04-06 Pyrrolidine dithiocarbamate administered during ex-vivo lung perfusion promotes rehabilitation of injured donor rat lungs obtained after prolonged warm ischemia Francioli, Cyril Wang, Xingyu Parapanov, Roumen Abdelnour, Etienne Lugrin, Jérôme Gronchi, Fabrizio Perentes, Jean Eckert, Philippe Ris, Hans-Beat Piquilloud, Lise Krueger, Thorsten Liaudet, Lucas PLoS One Research Article Damaged lung grafts obtained after circulatory death (DCD lungs) and warm ischemia may be at high risk of reperfusion injury after transplantation. Such lungs could be pharmacologically reconditioned using ex-vivo lung perfusion (EVLP). Since acute inflammation related to the activation of nuclear factor kappaB (NF-κB) is instrumental in lung reperfusion injury, we hypothesized that DCD lungs might be treated during EVLP by pyrrolidine dithiocarbamate (PDTC), an inhibitor of NF-κB. Rat lungs exposed to 1h warm ischemia and 2 h cold ischemia were subjected to EVLP during 4h, in absence (CTRL group, N = 6) or in presence of PDTC (2.5g/L, PDTC group, N = 6). Static pulmonary compliance (SPC), peak airway pressure (PAWP), pulmonary vascular resistance (PVR), and oxygenation capacity were determined during EVLP. After EVLP, we measured the weight gain of the heart-lung block (edema), and the concentration of LDH (cell damage), proteins (permeability edema) and of the cytokines IL-6, TNF-α and CINC-1 in bronchoalveolar lavage (BAL), and we evaluated NF-κB activation by the degree of phosphorylation and degradation of its inhibitor IκBα in lung tissue. In CTRL, we found significant NF-κB activation, lung edema, and a massive release of LDH, proteins and cytokines. SPC significantly decreased, PAWP and PVR increased, while oxygenation tended to decrease. Treatment with PDTC during EVLP inhibited NF-κB activation, did not influence LDH release, but markedly reduced lung edema and protein concentration in BAL, suppressed TNFα and IL-6 release, and abrogated the changes in SPC, PAWP and PVR, with unchanged oxygenation. In conclusion, suppression of innate immune activation during EVLP using the NF-κB inhibitor PDTC promotes significant improvement of damaged rat DCD lungs. Future studies will determine if such rehabilitated lungs are suitable for in vivo transplantation. Public Library of Science 2017-03-21 /pmc/articles/PMC5360331/ /pubmed/28323904 http://dx.doi.org/10.1371/journal.pone.0173916 Text en © 2017 Francioli et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Francioli, Cyril
Wang, Xingyu
Parapanov, Roumen
Abdelnour, Etienne
Lugrin, Jérôme
Gronchi, Fabrizio
Perentes, Jean
Eckert, Philippe
Ris, Hans-Beat
Piquilloud, Lise
Krueger, Thorsten
Liaudet, Lucas
Pyrrolidine dithiocarbamate administered during ex-vivo lung perfusion promotes rehabilitation of injured donor rat lungs obtained after prolonged warm ischemia
title Pyrrolidine dithiocarbamate administered during ex-vivo lung perfusion promotes rehabilitation of injured donor rat lungs obtained after prolonged warm ischemia
title_full Pyrrolidine dithiocarbamate administered during ex-vivo lung perfusion promotes rehabilitation of injured donor rat lungs obtained after prolonged warm ischemia
title_fullStr Pyrrolidine dithiocarbamate administered during ex-vivo lung perfusion promotes rehabilitation of injured donor rat lungs obtained after prolonged warm ischemia
title_full_unstemmed Pyrrolidine dithiocarbamate administered during ex-vivo lung perfusion promotes rehabilitation of injured donor rat lungs obtained after prolonged warm ischemia
title_short Pyrrolidine dithiocarbamate administered during ex-vivo lung perfusion promotes rehabilitation of injured donor rat lungs obtained after prolonged warm ischemia
title_sort pyrrolidine dithiocarbamate administered during ex-vivo lung perfusion promotes rehabilitation of injured donor rat lungs obtained after prolonged warm ischemia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360331/
https://www.ncbi.nlm.nih.gov/pubmed/28323904
http://dx.doi.org/10.1371/journal.pone.0173916
work_keys_str_mv AT franciolicyril pyrrolidinedithiocarbamateadministeredduringexvivolungperfusionpromotesrehabilitationofinjureddonorratlungsobtainedafterprolongedwarmischemia
AT wangxingyu pyrrolidinedithiocarbamateadministeredduringexvivolungperfusionpromotesrehabilitationofinjureddonorratlungsobtainedafterprolongedwarmischemia
AT parapanovroumen pyrrolidinedithiocarbamateadministeredduringexvivolungperfusionpromotesrehabilitationofinjureddonorratlungsobtainedafterprolongedwarmischemia
AT abdelnouretienne pyrrolidinedithiocarbamateadministeredduringexvivolungperfusionpromotesrehabilitationofinjureddonorratlungsobtainedafterprolongedwarmischemia
AT lugrinjerome pyrrolidinedithiocarbamateadministeredduringexvivolungperfusionpromotesrehabilitationofinjureddonorratlungsobtainedafterprolongedwarmischemia
AT gronchifabrizio pyrrolidinedithiocarbamateadministeredduringexvivolungperfusionpromotesrehabilitationofinjureddonorratlungsobtainedafterprolongedwarmischemia
AT perentesjean pyrrolidinedithiocarbamateadministeredduringexvivolungperfusionpromotesrehabilitationofinjureddonorratlungsobtainedafterprolongedwarmischemia
AT eckertphilippe pyrrolidinedithiocarbamateadministeredduringexvivolungperfusionpromotesrehabilitationofinjureddonorratlungsobtainedafterprolongedwarmischemia
AT rishansbeat pyrrolidinedithiocarbamateadministeredduringexvivolungperfusionpromotesrehabilitationofinjureddonorratlungsobtainedafterprolongedwarmischemia
AT piquilloudlise pyrrolidinedithiocarbamateadministeredduringexvivolungperfusionpromotesrehabilitationofinjureddonorratlungsobtainedafterprolongedwarmischemia
AT kruegerthorsten pyrrolidinedithiocarbamateadministeredduringexvivolungperfusionpromotesrehabilitationofinjureddonorratlungsobtainedafterprolongedwarmischemia
AT liaudetlucas pyrrolidinedithiocarbamateadministeredduringexvivolungperfusionpromotesrehabilitationofinjureddonorratlungsobtainedafterprolongedwarmischemia